The University of Minnesota filed a 300-page response late Tuesday to an inquiry from a prominent U.S. senator who is probing financial relationships between medical device companies and doctors, including one at the university's medical school.
Sen. Charles Grassley, R-Iowa, appears particularly interested in the alliance between Fridley-based Medtronic Inc. and Dr. David Polly, a prominent surgeon who heads the medical school's spine surgery unit.
In a letter dated Aug. 25, university General Counsel Mark Rotenberg said Polly disclosed his relationship with Medtronic both in research grants and while participating in clinical studies.
Previous correspondence between Grassley's office and the U indicated that Medtronic paid Polly about $1.2 million from 2003 to 2007 for consulting services, honoraria and expenses. For four consecutive years, Polly received more than $200,000 annually from Medtronic.
Medical device makers such as Medtronic say such consulting relationships help them understand how their products work in the field and how they can be improved. Critics, however, say the arrangements may constitute a conflict of interest that can negatively affect patient care.
Late last month, Grassley sent a 142-page letter to university President Robert Bruininks asking how the school manages potential conflicts of interest in these relationships, as well as specific questions regarding Polly's role in several research studies.
The U has already launched its own investigation into Polly's compliance with its conflict of interest policies. Medtronic also is investigating Polly's billings.
In his response, Rotenberg noted that the U requires faculty and staff to complete a form disclosing professional activities and business and financial interests of a "significant" nature -- defined as $10,000 or a 5 percent equity stake in a company. About 9,000 U employees must complete this form.